Endometrial Cancer (MSK, 2018): MSK-IMPACT sequencing of 197 advanced-staged endometrial cancer tumor samples with matched normals, from 189 patients treated at MSK.

This dataset contains summary data visualizations and clinical data from a broad sampling of endometrial tumors. The data was gathered utilizing the MSK-IMPACT targeted sequencing test. The clinical data includes tumor type (based on the opensource OncoTree ontology developed at MSK), mutation count, information about mutated genes, Fraction Genome Altered, First-Line Therapy PFS, IHC Detail, MMR-D by IHC, MSI Status, Neoplasm Histologic Grade, POLE ultra-mutated, Progression Status, SCNA Cluster, and Oncotree Code. The data set also includes copy-number segment data downloadable as .seg files and viewable via the Integrative Genomics Viewer.

本数据集汇集了来自广泛样本子宫内膜肿瘤的摘要数据可视化与临床数据。数据收集采用了MSK-IMPACT靶向测序测试。临床数据包括肿瘤类型（基于MSK开发的开源OncoTree本体），突变计数，突变基因信息，基因组改变分数，一线治疗方案的无进展生存期（PFS），免疫组化细节，微卫星不稳定性（MMR-D）通过免疫组化检测，微卫星不稳定性状态，肿瘤组织学分级，POLE超突变，进展状态，SCNA簇，以及Oncotree代码。此外，数据集还包括可下载为.seg文件的拷贝数分段数据，并通过综合基因组学查看器进行查看。